This report examines how global pricing pressure is driving a 9.6% decline in UK Medical Affairs hiring for 2025, with London remaining resilient and Wales surging. It highlights the contraction among major pharma, contrasted with growth in CROs and biotechs, and shows how AI is reshaping support roles while core scientific expertise remains in demand.
With the slump in the pharmaceutical sector set to continue, the long-awaited reforms to the MHRA have yet to materialise. As a result, drug approval in the UK lags behind the EU, further depressing the sector. 2023 seems to be the low point in that there has been an uptick in Q1 so far, and if this continues, it will increase by 9.1% this year compared to last. The recovery has been in London specifically, with volumes up 26.1% on last year.
Vacancies for UK medical affairs professionals in Q1 2021 reached a level not seen in three years according to data from Cpl Life Sciences and Vacancysoft.
